A key U.S. government trial of Gilead Sciences Inc's experimental coronavirus treatment may yield results as early as mid-May, according to the study's lead investigator, after doctors clamored to enroll their patients in the study.
Gilead pushed back on that interpretation saying the study, which was stopped early due to low patient enrollment, cannot provide meaningful conclusions.Doctors at Houston Methodist Hospital told Reuters that since March 23, they have treated 41 mostly severely ill COVID-19 patients with the drug. None have died and half are back home.
It is a randomized, double-blind study in which half the patients were given the drug and the other half a placebo. Enrollment in the trial closed on Sunday, but has far exceeded initial goals of 400 to 500 patients, he said. A lack of hard evidence has given U.S. medical associations, as well as the National Institutes of Health, pause. They have not recommended remdesivir to treat COVID-19.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead disputes report that its drug flopped in leaked coronavirus trial[BENGALURU] A closely-watched Gilead Sciences experimental antiviral drug failed to help patients with severe Covid-19 in a clinical trial conducted in China, but the drugmaker said the findings were inconclusive because the study was terminated early. Read more at The Business Times. Wait for remdesivir US control trials by April 30, those that are untainted by geopolitics. You believe the WHO didn't do this 'accidental' publication of unfinished trial on purpose? Thirty days after Chinese Govt approved Fujifilm similar Avigan antiviral as first COVID drug?
Source: BusinessTimes - 🏆 15. / 51 Read more »
Gilead disputes report that its drug flopped in leaked coronavirus trialFOSTER CITY, CALIFORNIA (REUTERS) - A closely-watched Gilead Sciences Inc experimental antiviral drug failed to help patients with severe Covid-19 in a clinical trial conducted in China, but the drugmaker said the findings were inconclusive because the study was terminated early.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
Gilead disputes report that its drug flopped in leaked coronavirus trial[BENGALURU] A closely-watched Gilead Sciences experimental antiviral drug failed to help patients with severe Covid-19 in a clinical trial conducted in China, but the drugmaker said the findings were inconclusive because the study was terminated early. Read more at The Business Times. Wait for remdesivir US control trials by April 30, those that are untainted by geopolitics. You believe the WHO didn't do this 'accidental' publication of unfinished trial on purpose? Thirty days after Chinese Govt approved Fujifilm similar Avigan antiviral as first COVID drug?
Source: BusinessTimes - 🏆 15. / 51 Read more »
Gilead disputes report that its drug flopped in leaked coronavirus trialFOSTER CITY, CALIFORNIA (REUTERS) - A closely-watched Gilead Sciences Inc experimental antiviral drug failed to help patients with severe Covid-19 in a clinical trial conducted in China, but the drugmaker said the findings were inconclusive because the study was terminated early.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
Experimental coronavirus drug remdesivir failed in human trialNEW YORK: The experimental coronavirus treatment remdesivir has failed in its first randomized clinical trial, inadvertently released results ... Cuban medicine seems to help in the fight against COVID 19 See how the coverage compares against other news outlets on Ground News remdesivir Coronavirus WorldHealthOrganization Medical Science they'll try again
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
S&P 500 slips after report on coronavirus drug trialWall Street's main indexes pared gains sharply on Thursday, after a report that Gilead Sciences experimental coronavirus drug flopped in its first ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »